Integra LifeSciences Holdings Corporation (IART)
NASDAQ · Healthcare
Integra LifeSciences Holdings Corporation Operating Income 2016–2025
Integra LifeSciences Holdings Corporation annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Integra LifeSciences Holdings Corporation operating income for the quarter ending March 31, 2026 was 11.5 M, a 174.01% decrease year-over-year.
- Integra LifeSciences Holdings Corporation operating income for the twelve months ending March 31, 2026 was -504.9 M, a 2705.74% decrease year-over-year.
- Integra LifeSciences Holdings Corporation annual operating income for 2025 was -493.4 M, a 1836.55% decrease from 2024.
- Integra LifeSciences Holdings Corporation annual operating income for 2024 was 28.4 M, a 74.53% decrease from 2023.
- Integra LifeSciences Holdings Corporation annual operating income for 2023 was 111.5 M, a 53.32% decrease from 2022.
- Integra LifeSciences Holdings Corporation annual operating income for 2022 was 238.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Integra LifeSciences Holdings Corporation Operating Income — FAQ
Integra LifeSciences Holdings Corporation (IART) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Integra LifeSciences Holdings Corporation's operating income?
Integra LifeSciences Holdings Corporation (IART) reported operating income of -$493M for fiscal 2025.
Where can I see IART's operating income history?
The chart and table above show Integra LifeSciences Holdings Corporation's operating income by year and by quarter, including the growth rate.